Cost of therapy for dermatophyte infections

Tinea capitis asymptomatic carriers: what is the evidence behind treatment?

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Mycetoma - a history of the first contributions to the description of the disease and its pathogenesis.

Transactions of the Royal Society of Tropical Medicine and Hygiene·2020

Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial.

The British journal of dermatology·2020

Estimating the global burden of scabies: what else do we need?

The British journal of dermatology·2020

The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies.

The British journal of dermatology·2020

Validation of the integrated 40-gene expression profile (i40-GEP) which provides prognostic and adjuvant radiation benefit for high-risk cutaneous squamous cell carcinoma.

Journal of the American Academy of Dermatology·2026

The Effects of Tildrakizumab in the Epigenetic Aging Deviation of Psoriasis: A 52-Week Open-Label Study.

Journal of the American Academy of Dermatology·2026

Metagenomic Characterization of Nitrite-Negative Urinary Tract Infections and Identification of an optrA-fexA Co-Localization in a Primary Healthcare Setting in China.

Infection and drug resistance·2026

Impact of medium composition on cefiderocol susceptibility testing: comparison of CLSI/EUCAST-compliant and commercial broth microdilution methods.

JAC-antimicrobial resistance·2026

Case Report: Methemoglobinemia associated with compound aminopyrine-phenacetin tablets supported by toxicological evidence.

Frontiers in pharmacology·2026

Genomic characterization of drug-resistant Mycobacterium tuberculosis complex in western Kenya reveals predominance of isoniazid resistance and discordance with routine susceptibility testing.

Frontiers in tuberculosis·2026

Innovative laboratory methods for improved tuberculosis diagnosis and drug-susceptibility testing.

Frontiers in tuberculosis·2026

Novel diagnostic test for the detection of Mycobacterium tuberculosis and its resistance to rifampicin, isoniazid, and fluoroquinolones directly in sputum samples.

Frontiers in tuberculosis·2026

Related Experiment Videos

Cost of therapy for dermatophyte infections

Related Concept Videos

Tinea capitis asymptomatic carriers: what is the evidence behind treatment?

Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic.

Mycetoma - a history of the first contributions to the description of the disease and its pathogenesis.

Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial.

Estimating the global burden of scabies: what else do we need?

The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies.

Validation of the integrated 40-gene expression profile (i40-GEP) which provides prognostic and adjuvant radiation benefit for high-risk cutaneous squamous cell carcinoma.

The Effects of Tildrakizumab in the Epigenetic Aging Deviation of Psoriasis: A 52-Week Open-Label Study.

Metagenomic Characterization of Nitrite-Negative Urinary Tract Infections and Identification of an optrA-fexA Co-Localization in a Primary Healthcare Setting in China.

Impact of medium composition on cefiderocol susceptibility testing: comparison of CLSI/EUCAST-compliant and commercial broth microdilution methods.

Case Report: Methemoglobinemia associated with compound aminopyrine-phenacetin tablets supported by toxicological evidence.

Genomic characterization of drug-resistant Mycobacterium tuberculosis complex in western Kenya reveals predominance of isoniazid resistance and discordance with routine susceptibility testing.

Innovative laboratory methods for improved tuberculosis diagnosis and drug-susceptibility testing.

Novel diagnostic test for the detection of Mycobacterium tuberculosis and its resistance to rifampicin, isoniazid, and fluoroquinolones directly in sputum samples.

Related Experiment Videos

Cost of therapy for dermatophyte infections

Related Concept Videos

Related Articles